Iterum Therapeutics plc (ITRMF) Other Accumulated Expenses (2017 - 2025)

Iterum Therapeutics' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $241000.0 for Q3 2025.

• In Q3 2025, Other Accumulated Expenses fell 63.92% year-over-year to $241000.0; the TTM figure through Sep 2025 stood at $241000.0 (down 63.92% YoY), while the FY2024 annual figure was $240000.0, down 68.46% from the prior year.
• Other Accumulated Expenses for Q3 2025 stood at $241000.0, up from $197000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $4.3 million in Q2 2021, with the low at $194000.0 in Q2 2023.
• The 5-year median for Other Accumulated Expenses is $320000.0 (2023), against an average of $716105.3.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses tumbled 90.57% in 2022, then surged 245.91% in 2023.
• Iterum Therapeutics' Other Accumulated Expenses stood at $256000.0 in 2021, then decreased by 14.06% to $220000.0 in 2022, then soared by 245.91% to $761000.0 in 2023, then plunged by 68.46% to $240000.0 in 2024, then rose by 0.42% to $241000.0 in 2025.
• Business Quant data shows ITRMF's Other Accumulated Expenses at $241000.0 in Q3 2025, $197000.0 in Q2 2025, and $201000.0 in Q1 2025.